Al-Farabi Kazakh National University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT03138785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Al-Farabi Kazakh National University | Al-Farabi Kazakh National University (KazNU) | Farabi Eye Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Edema (Phase 2)

Keratoconjunctivitis (Phase 2)

Macular Edema (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6